IP Library › Assignment 020471/0954
Patent Assignment
Reel/Frame 020471/0954

Change of Name

Recorded: 2008-02-06 Pages: 20
Assignor
RIBOPHARMA AG
Executed: 2004-05-27
Assignee
ALNYLAM EUROPE AG
FRITZ-HORNSCHUCH-STR. 9, KULMBACH, 95326, GERMANY
Covered Property (1)
Method and medicament for inhibiting the expression of a given gene
Patent: 8,729,037 →
Application: 11/982,345 →
Publication: US 2008/0261303
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 6, 2008
From: KREUTZER, ROLAND; WIRSING, JOHANN N.; LIMMER, STEFAN; HOFFMAN, SONJA
To: RIBOPHARMA AG
Reel/Frame 020471/0443 →
Corrective Assignment to Correct the Assignor Information Previously Recorded on Reel 020471 Frame 0443. Assignor(S) Hereby Confirms the Assignment. Mar 4, 2008
From: KREUTZER, ROLAND; LIMMER, STEFAN
To: RIBOPHARMA AG
Reel/Frame 020597/0869 →
Assignment of Assignor's Interest Aug 7, 2009
From: ALNYLAM EUROPE AG
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 023070/0300 →